ClinConnect ClinConnect Logo
Search / Trial NCT04862000

Observational Study of Patients Suffering From Endometriosis and Adenomyosis

Launched by CHINESE UNIVERSITY OF HONG KONG · Apr 26, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Endometriosis Adenomyosis

ClinConnect Summary

This clinical trial is looking at women who have endometriosis or adenomyosis, which are conditions that can cause chronic pain and other symptoms. The goal of the study is to gather information about the health and quality of life of these women. Researchers will use questionnaires to learn more about their reproductive health and the unique features of their conditions. They want to identify factors that might lead to more severe cases and suggest the best treatment options for different patient groups, whether they wish to have children or not.

To participate in this study, women need to be between 18 and 74 years old and must have a diagnosis of endometriosis or adenomyosis confirmed through an ultrasound or MRI scan. Those who do not wish to participate, are menopausal, or cannot understand the study will not be included. Participants can expect to share their experiences through structured questionnaires and contribute to valuable research that may help improve care and treatment options for women with these conditions in the future.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • with endometriosis or adenomyosis confirmed by ultrasound or MRI
  • Exclusion Criteria:
  • refuse to participate in the study, less than 18 years old, menopausal, illiterate or mentally incapable

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Hong Kong, , Hong Kong

Patients applied

EL

1 patients applied

Trial Officials

Wen Ying Linda FUNG

Principal Investigator

Chinese University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials